Medical Device Market Access Support

Entering South Africa should not require an international medical device manufacturer to rebuild its regulatory organisation from the ground up.

Most established manufacturers already have extensive product knowledge, technical documentation, quality systems, international regulatory approvals and internal procedures. The challenge is determining how that existing infrastructure translates into the South African regulatory and operating environment.

That is where Verion Medical is positioned to support international manufacturers.

We work across the regulatory and operational requirements that sit between an overseas manufacturer and a functioning South African market presence. This includes device classification, regulatory pathway assessment, technical documentation, establishment licensing, quality-system alignment, import readiness, distribution structures and local market development.

The objective is not simply to answer whether a device can be sold in South Africa.

It is to establish a practical route through which the manufacturer can enter the market, supply products compliantly and maintain the local regulatory structure as its portfolio develops.

South Africa’s Medical Device Regulations establish requirements covering matters including importation, establishment licensing, registration and device classification. SAHPRA’s March 2023 licensing guidance further addresses licences for establishments that manufacture, import, export or distribute medical devices and IVDs.

For an international manufacturer, those requirements need to be translated into a local operating model.

That is the role Verion Medical is designed to support.

Why South African market entry needs local regulatory planning

An international manufacturer may already sell the same medical device across multiple regulated markets.

That experience is valuable, but it does not eliminate the need for a South African regulatory assessment.

South Africa has its own legislation, classification framework and medical device establishment licensing system.

The Regulations Relating to Medical Devices and In Vitro Diagnostic Medical Devices contain specific provisions addressing importation, establishment licences and medical device and IVD classification.

SAHPRA’s March 2023 classification guideline confirms that medical devices and IVDs are classified according to South African rules and that classification supports the establishment licensing and product regulatory framework.

An international manufacturer should therefore resist the temptation to begin with a shipment. The stronger sequence is to begin with the regulatory structure.

Start with the product, not the application form

One of the most common ways to complicate medical device market entry is to begin with the application document before the regulatory pathway has been defined.

Verion Medical begins with the product.

We seek to understand the device, intended purpose, users, patient population, IVD status where relevant, international regulatory position, supply model, original manufacturer, intended local importer or distributor and available technical evidence.

Only then should the organisation determine which regulatory activities are required.

This helps preserve useful existing manufacturer evidence while identifying the South African requirements that genuinely need to be addressed.

Confirm whether the product is a medical device or IVD

Before classification or licensing, the manufacturer should establish whether the product falls within South Africa’s medical device or IVD framework.

This can require particular attention for software, accessories, laboratory systems and technologies used in healthcare that may not necessarily perform a regulated medical function.

The intended purpose and associated claims should remain consistent across technical documentation, instructions and commercial information.

Our medical device regulatory affairs services support early regulatory pathway assessments.

Establish the South African classification

South Africa uses a risk-based Class A, B, C and D framework for medical devices and IVDs.

The classification should be determined under the applicable South African rules rather than adopted automatically from another jurisdiction.

Verion Medical’s device classification services support international manufacturers with documented application of the South African classification framework.

See Medical Device Classification in South Africa: Classes A, B, C and D.

Determine the local regulatory operating model

Once the product pathway is understood, the manufacturer needs to decide how it will operate in South Africa.

This can involve a South African distributor, the manufacturer’s own local entity or a combination of regulatory, logistics and commercial partners.

The correct structure depends on the portfolio, import strategy, warehousing, sales channels, technical support, desired control and long-term market objectives.

The regulatory structure should reflect the actual activities that will be performed.

Understand establishment licensing before appointing partners

South Africa regulates establishments involved in medical device manufacturing, importation, exportation and distribution.

Before relying on a local partner, the manufacturer should understand the licensed legal entity, licence type, site, activities and regulatory scope.

A commercial description such as “distributor” does not itself establish what the organisation is regulatorily authorised to do.

Verion Medical’s SAHPRA establishment licensing services support both South African companies and international manufacturers assessing an appropriate local structure.

Align the manufacturer, importer and distributor structure

The responsibilities of the manufacturer, importer and distributor should be clearly defined.

The parties should establish who imports the products, receives them, stores them, distributes them, maintains regulatory information, handles complaints and communicates relevant product changes.

Where several organisations are involved, their responsibilities should form one coherent operating model.

Make existing technical documentation work for South Africa

Established manufacturers often already hold substantial regulatory evidence.

This can include device descriptions, risk-management records, verification and validation, clinical evidence, manufacturing information, international approvals, labels and instructions for use.

The objective should generally be to assess how this existing evidence supports the South African pathway and identify any gaps rather than recreate every document unnecessarily.

Our technical documentation and labelling services support this assessment.

Identify technical-documentation gaps early

Potential gaps are easier to resolve before a commercial launch date or shipment has been committed.

Examples can include inconsistent intended-purpose statements, missing model information, outdated certificates, differences between labels and technical documentation or insufficient evidence for the configuration proposed for South Africa.

An early gap assessment allows the manufacturer to distinguish genuine regulatory work from documentation that already exists and remains usable.

Align the Quality Management System with local operations

The international manufacturer’s global QMS and the South African operating processes need appropriate interfaces.

Local controls may be required for document management, training, storage, distribution, complaints, recalls, regulatory changes and quality records.

Information must also flow in both directions.

South African complaints need an agreed route back to the manufacturer, while product changes originating globally need to reach the South African regulatory function before local implementation.

Verion Medical’s ISO 13485 and Quality Management Systems services support the development of these operational controls.

Prepare the import pathway before the first shipment

Importation should follow regulatory readiness rather than precede it.

Before a commercial shipment leaves the manufacturer, the parties should know the importer, applicable establishment structure, product identity, destination, storage arrangements and regulatory responsibilities.

Our import and export services support companies in aligning medical-device regulatory readiness with physical product movement.

Build distribution controls around the actual supply chain

Once devices enter South Africa, the organisation needs controlled distribution information.

This can include stock, traceability, customer records, storage, product returns, complaints, changes and recalls.

The international manufacturer should retain appropriate visibility into information arising from the local market.

The South African supply chain should therefore support regulatory communication as well as commercial distribution.

Keep regulatory and commercial strategy connected

Commercial changes can have regulatory consequences.

Changes to the importer, distribution channels, product portfolio or locally performed activities can affect the regulatory structure.

Verion Medical’s market development services therefore connect route-to-market planning with the regulatory operating model.

The commercial strategy should be capable of operating within the structure established for compliance.

Why distributor selection needs regulatory due diligence

International manufacturers should evaluate distributors as regulatory and operational partners as well as sales organisations.

Due diligence should consider the prospective distributor’s regulatory structure, quality system, warehousing, complaint handling, technical capability, relevant market experience and information-sharing arrangements.

A distributor should be selected because it fits the manufacturer’s complete South African operating model rather than solely because it has access to customers.

Protect visibility over the manufacturer’s own products

The manufacturer should maintain appropriate visibility over the South African regulatory position of its portfolio.

This includes knowing which products are maintained locally, which changes have been made, whether relevant licences remain current and what happens to regulatory records if the commercial relationship ends.

Information continuity should therefore be addressed when the local structure is established.

Prepare for product and portfolio changes

Medical device portfolios change over time.

Manufacturers introduce new models, revise software, update labels, change manufacturing arrangements and discontinue products.

The South African operating model should include a mechanism for assessing the local impact of relevant global changes before implementation.

This helps prevent the manufacturer’s current product from gradually diverging from the regulatory information maintained in South Africa.

Support does not end with initial market entry

Market entry is a milestone rather than the end of the medical-device regulatory lifecycle.

Companies continue to manage licences, product information, regulatory changes, quality records, complaints, supply continuity, new products and other lifecycle obligations.

Verion Medical’s regulatory-operations approach is intended to support this transition from initial entry into ongoing market participation.

How Verion Medical works with international manufacturers

Our approach begins with understanding what the manufacturer already has.

We review the product portfolio, existing approvals, technical documentation, QMS, proposed South African operating model and commercial objectives.

Those elements can then be mapped against the South African pathway to identify the actual work required.

Some manufacturers may require primarily regulatory and licensing support. Others may need technical documentation, local quality interfaces, import readiness and broader market-development support.

The pathway should fit the manufacturer rather than forcing every company through an identical package.

A practical South African market-entry pathway

A structured international-manufacturer pathway can include:

defining the intended South African product portfolio;
confirming medical device or IVD status;
determining South African classification;
reviewing existing technical evidence;
defining the local importer and distribution model;
confirming the establishment licensing structure;
aligning the international and local quality systems;
resolving technical-documentation and labelling gaps;
preparing import and distribution controls;
establishing complaint, change and information-management processes; and
connecting the regulatory structure with commercial market development.

This provides a more controlled pathway than treating the first shipment as the beginning of the South African regulatory process.

Why Verion Medical is structured for international manufacturers

Verion Medical connects the regulatory and operational workstreams that international manufacturers need to establish a South African presence.

Our capabilities include medical device registration support, device classification, technical documentation and labelling, establishment licensing, ISO 13485 and Quality Management Systems, regulatory affairs, import and export support and market development.

The manufacturer can therefore assess its South African pathway as one connected programme rather than a collection of unrelated tasks.

Key regulatory references

How Verion Medical can support your South African market entry

Verion Medical supports international medical device and IVD manufacturers that need a practical South African regulatory and operating pathway.

We can support the manufacturer from initial regulatory assessment through classification, local licensing strategy, technical-documentation review, quality-system alignment, import readiness and commercial market-entry planning.

The process is designed around the manufacturer’s existing infrastructure.

Where suitable global regulatory evidence already exists, our role is to determine how that evidence can support the South African pathway and where additional work is genuinely required.

Where the local operating structure still needs to be established, we can help connect the regulatory requirements with the proposed importer, distributor, quality and supply-chain model.

The objective is not merely to reach the first shipment. It is to establish a South African market-entry structure that the manufacturer can understand, control and maintain as its local business develops.

If your organisation is considering South Africa for a medical device or IVD portfolio, contact Verion Medical to assess the regulatory and operational pathway before appointing partners or planning the first shipment.